CREDO TECHNOLOGY GROUP HOLDI (CRDO)

KYG254571055 - Common Stock

69.01  -1.68 (-2.38%)

After market: 69.75 +0.74 (+1.07%)

Fundamental Rating

4

CRDO gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 108 industry peers in the Semiconductors & Semiconductor Equipment industry. No worries on liquidiy or solvency for CRDO as it has an excellent financial health rating, but there are worries on the profitability. CRDO is valued quite expensive, but it does show an excellent growth.



1

1. Profitability

1.1 Basic Checks

CRDO had positive earnings in the past year.
In the past year CRDO had a positive cash flow from operations.
In the past 5 years CRDO always reported negative net income.
CRDO had negative operating cash flow in 4 of the past 5 years.

1.2 Ratios

With a Return On Assets value of -4.06%, CRDO is not doing good in the industry: 65.74% of the companies in the same industry are doing better.
With a Return On Equity value of -4.74%, CRDO is not doing good in the industry: 63.89% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -4.06%
ROE -4.74%
ROIC N/A
ROA(3y)-4.92%
ROA(5y)-6.49%
ROE(3y)-5.55%
ROE(5y)-7.19%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

CRDO's Gross Margin of 62.47% is amongst the best of the industry. CRDO outperforms 87.96% of its industry peers.
In the last couple of years the Gross Margin of CRDO has declined.
CRDO does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 62.47%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.74%
GM growth 5YN/A

8

2. Health

2.1 Basic Checks

CRDO does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, CRDO has more shares outstanding
CRDO has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

2.2 Solvency

CRDO has an Altman-Z score of 77.47. This indicates that CRDO is financially healthy and has little risk of bankruptcy at the moment.
CRDO has a Altman-Z score of 77.47. This is amongst the best in the industry. CRDO outperforms 98.15% of its industry peers.
There is no outstanding debt for CRDO. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 77.47
ROIC/WACCN/A
WACC14.99%

2.3 Liquidity

A Current Ratio of 7.81 indicates that CRDO has no problem at all paying its short term obligations.
CRDO's Current ratio of 7.81 is amongst the best of the industry. CRDO outperforms 92.59% of its industry peers.
A Quick Ratio of 7.36 indicates that CRDO has no problem at all paying its short term obligations.
CRDO's Quick ratio of 7.36 is amongst the best of the industry. CRDO outperforms 93.52% of its industry peers.
Industry RankSector Rank
Current Ratio 7.81
Quick Ratio 7.36

7

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 2300.00% over the past year.
Looking at the last year, CRDO shows a small growth in Revenue. The Revenue has grown by 4.76% in the last year.
The Revenue has been growing by 48.69% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)2300%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%600%
Revenue 1Y (TTM)4.76%
Revenue growth 3Y48.69%
Revenue growth 5YN/A
Sales Q2Q%63.57%

3.2 Future

CRDO is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 133.79% yearly.
Based on estimates for the next years, CRDO will show a very strong growth in Revenue. The Revenue will grow by 49.41% on average per year.
EPS Next Y309.51%
EPS Next 2Y197.19%
EPS Next 3Y133.79%
EPS Next 5YN/A
Revenue Next Year65.44%
Revenue Next 2Y59.86%
Revenue Next 3Y49.41%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 313.68, which means the current valuation is very expensive for CRDO.
CRDO's Price/Earnings ratio is a bit more expensive when compared to the industry. CRDO is more expensive than 60.19% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 29.59. CRDO is valued rather expensively when compared to this.
With a Price/Forward Earnings ratio of 86.81, CRDO can be considered very expensive at the moment.
Based on the Price/Forward Earnings ratio, CRDO is valued a bit more expensive than 60.19% of the companies in the same industry.
CRDO's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 24.06.
Industry RankSector Rank
PE 313.68
Fwd PE 86.81

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

CRDO's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
CRDO's earnings are expected to grow with 133.79% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.01
PEG (5Y)N/A
EPS Next 2Y197.19%
EPS Next 3Y133.79%

0

5. Dividend

5.1 Amount

CRDO does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

CREDO TECHNOLOGY GROUP HOLDI

NASDAQ:CRDO (12/4/2024, 8:00:00 PM)

After market: 69.75 +0.74 (+1.07%)

69.01

-1.68 (-2.38%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap11.46B
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 313.68
Fwd PE 86.81
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)1.01
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -4.06%
ROE -4.74%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 62.47%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.34
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 7.81
Quick Ratio 7.36
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)2300%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next Y309.51%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)4.76%
Revenue growth 3Y48.69%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y